JAGUAR HEALTH, INC. Line of Credit Facility, Maximum Borrowing Capacity
JAGUAR HEALTH, INC. (JAGX) had Line of Credit Facility, Maximum Borrowing Capacity of $8.00 million as of 2015-08-18, per its 10-Q filed 2018-05-15.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2018-05-15
- 2015-08-18: Line of Credit Facility, Maximum Borrowing Capacity $8.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2015-08-18 | $8.00M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |